Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

AERIE PHARMACEUTICALS INC (AERI)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14
   10-K10-K10-K10-K10-K10-K10-K10-K
Total revenues, net  194.183.169.924.2    
            Total revenues, net growth  133.5%19.0%189.0%     
Costs and expenses:          
Cost of goods sold  26.825.34.80.6    
Selling, general, and administrative  137.8137.2138.4120.656.934.730.620.1
Research and development  75.874.091.486.172.152.444.529.9
    Total costs and expenses  240.5238.8257.4233.9145.796.9  
    Loss from operations  -46.4-155.7-187.5-209.7-145.7-96.9-75.1-50.0
            Operating margin  -23.9%-187.3%-268.3%-867.4%    
Other expense, net  -27.9-22.2-12.2-22.8-1.2-2.00.91.8
    Loss before income taxes  -74.2-177.9-199.7-232.6-146.9-98.9-74.2-48.1
Income tax expense  0.65.2-0.10.0-1.80.20.1 
    Net loss  -74.8-183.1-199.6-232.6-145.1-99.1-74.4-48.1
   
Net loss per common share—basic (in dollars per share)  ($1.61)($3.99)($4.39)($5.58)($4.11)($3.40)($2.88)($2.00)
Net loss per common share—diluted (in dollars per share)  ($1.61)($3.99)($4.39)($5.58)($4.11)($3.40)($2.88)($2.00)
   
Weighted average number of common shares outstanding—basic (in shares)  46.345.945.441.735.329.125.824.1
Weighted average number of common shares outstanding—diluted (in shares)  46.345.945.4     
Net loss  -74.8-183.1-199.6-232.6-145.1-99.1-74.4-48.1
    Comprehensive loss  -74.9-183.1-199.7-232.5-145.1-98.9-74.4 
   
Revenue from Contract with Customer, Product and Service [Extensible Enumeration]          

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy